JMPWA
PTCT icon

JP Morgan Private Wealth Advisors’s PTC Therapeutics PTCT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,267
Closed -$444K – 1788
2020
Q4 		$444K Buy
7,267
+41
+0.6% +$2.42K ﹤0.01% 1332
2020
Q3 		$338K Hold
7,226
– – ﹤0.01% 1309
2020
Q2 		$367K Hold
7,226
– – ﹤0.01% 1227
2020
Q1 		$322K Buy
7,226
+210
+3% +$10.6K ﹤0.01% 1103
2019
Q4 		$337K Hold
7,016
– – ﹤0.01% 1187
2019
Q3 		$237K Hold
7,016
– – ﹤0.01% 1280
2019
Q2 		$316K Sell
7,016
-2,818
-29% -$111K ﹤0.01% 1129
2019
Q1 		$370K Buy
9,834
+276
+3% +$9.27K ﹤0.01% 1129
2018
Q4 		$328K Buy
9,558
+380
+4% +$13.7K ﹤0.01% 1125
2018
Q3 		$431K Buy
9,178
+2,118
+30% +$87.6K ﹤0.01% 1128
2018
Q2 		$238K Buy
+7,060
New +$220K ﹤0.01% 1294
2017
Q2 		– Sell
-15,783
Closed -$155K – 1333
2017
Q1 		$155K Sell
15,783
-218
-1% -$2.64K ﹤0.01% 1270
2016
Q4 		$175K Buy
16,001
+3,184
+25% +$33.4K ﹤0.01% 1178
2016
Q3 		$180K Sell
12,817
-23
-0.2% -$187 ﹤0.01% 1157
2016
Q2 		$90K Buy
+12,840
New +$94.2K ﹤0.01% 1211

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Private Wealth Advisors's PTCT Position: Q1 2021 in Review

JP Morgan Private Wealth Advisors sold out of PTC Therapeutics (PTCT) in Q1 2021, closing a stake of 7,267 shares — an estimated $444K sold.

JP Morgan Private Wealth Advisors first reported a position in PTCT in Q2 2016 and held it in 15 quarters. The position peaked at $444K in Q4 2020. 207 funds tracked by Wall St. Rank hold PTCT as of Q1 2021.

  • JP Morgan Private Wealth Advisors reported no remaining PTC Therapeutics position as of Q1 2021 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 7,267 PTC Therapeutics shares in Q1 2021, an estimated $444K.
  • JP Morgan Private Wealth Advisors first reported a position in PTC Therapeutics in Q2 2016 and held it in 15 quarters.
  • JP Morgan Private Wealth Advisors's PTC Therapeutics position peaked at $444K in Q4 2020.
  • 207 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2021, filed 14 May 2021.